Patrocinados
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
Posted
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns with the company's expectation that 50% of its revenue will come from the U.S. by 2030. The decision comes amid rising tariff pressures from the Trump administration, aiming to bolster domestic drug supply chains.
Buscar
Categorías
- National
- International
- Business
- Technology
- Health
- Educación
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
WWE: Legendary wrestler Hulk Hogan dead at 71, reports US media
Hulk Hogan, the famous wrestler, is no more. Reports confirm his death at his Florida home. He...
Today’s News in a Nutshell
KATHMANDU: Khabarhub brings you a glimpse of major developments of the day in Nepal, including...
Hockey: Cash-strapped Pakistan might be forced to skip FIH Pro League despite invitation
Pakistan's potential return to international hockey faces uncertainty as financial constraints...
Prithviraj says Ibrahim deserved debut with Sarzameen, not Nadaaniyan
Prithviraj Sukumaran believes that Sarzameen would have been a more impactful debut for Ibrahim...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Spanish
